-+ 0.00%
-+ 0.00%
-+ 0.00%

BeOne Medicines CEO John Oyler disposes of $27,267,619 in common shares

PUBT·07/15/2026 01:26:07
Listen to the news
BeOne Medicines CEO John Oyler disposes of $27,267,619 in common shares
  • BeOne Medicines CEO John Oyler reported option exercises on July 10-13, then sold the resulting American Depositary Shares.
  • Disposed of 79,200 ADS in total at weighted-average prices near USD 296.07-307.41 per ADS.
  • Directly held ADS position fell to zero following the sales.
  • Exercised options for 782,834 ordinary shares at an exercise price of USD 2.84 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001042047-26-000011), on July 14, 2026, and is solely responsible for the information contained therein.